Corient Private Wealth’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,000
Closed -$42.5K 2303
2024
Q4
$42.5K Hold
10,000
﹤0.01% 2288
2024
Q3
$29.4K Sell
10,000
-21,960
-69% -$69.9K ﹤0.01% 2422
2024
Q2
$111K Buy
31,960
+19,960
+166% +$66.6K ﹤0.01% 2200
2024
Q1
$34.2K Buy
12,000
+2,000
+20% +$6.17K ﹤0.01% 2244
2023
Q4
$35.3K Hold
10,000
﹤0.01% 2216
2023
Q3
$25.9K Hold
10,000
﹤0.01% 2101
2023
Q2
$39.4K Hold
10,000
﹤0.01% 2028
2023
Q1
$33.8K Hold
10,000
﹤0.01% 1961
2022
Q4
$35.8K Buy
+10,000
New +$42.7K ﹤0.01% 1648

Other funds holding SRTA

Corient Private Wealth's SRTA Position: Q1 2025 in Review

Corient Private Wealth sold out of Strata Critical Medical Inc (SRTA) in Q1 2025, closing a stake of 10,000 shares — an estimated $42.5K sold.

Corient Private Wealth first reported a position in SRTA in Q4 2022 and held it in 9 quarters. The position peaked at $111K in Q2 2024. 118 funds tracked by Wall St. Rank hold SRTA as of Q1 2025.

  • Corient Private Wealth reported no remaining Strata Critical Medical Inc position as of Q1 2025 after selling out during the quarter.
  • Corient Private Wealth sold 10,000 Strata Critical Medical Inc shares in Q1 2025, an estimated $42.5K.
  • Corient Private Wealth first reported a position in Strata Critical Medical Inc in Q4 2022 and held it in 9 quarters.
  • Corient Private Wealth's Strata Critical Medical Inc position peaked at $111K in Q2 2024.
  • 118 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2025.

Based on Corient Private Wealth's 13F filing for Q1 2025, filed 14 May 2025.